<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53749">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02043431</url>
  </required_header>
  <id_info>
    <org_study_id>EMR-01</org_study_id>
    <nct_id>NCT02043431</nct_id>
  </id_info>
  <brief_title>Electronic Medical Records and Genomics</brief_title>
  <official_title>Genetic and Electronic Medical Records to Predict Outcomes in Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <authority>Brazil: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop a biobank containing samples of 2,000 patients
      treated in a tertiary cardiology hospital containing electronic medical records and genetic
      data in genome-wide scale for performing genetic association studies for validation and
      development of medical decision routines that help the clinical management of heart failure
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients between 18 and 80 years old with heart failure diagnosis of different etiologies
      and left ventricular ejection fraction &lt; 50% in the past 2 years will be eligible for
      enrollment on the cohort. After consent, patients will be submitted to clinical baseline,
      echocardiographic, cardiography impedance and biochemical evaluation. Study data will be
      collected and managed using Research Electronic Data Capture (REDCap) tools. The follow up
      will take place every 6 months to assess cardiovascular outcomes (all-cause mortality,
      cardiovascular mortality, hospitalization for worsening heart failure and current medication
      use). Initial analytical strategy will focus on the establishment of the accuracy of
      electronic medical records extraction protocols for main predictor factors of morbidity and
      mortality in heart failure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>six month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiovascular mortality</measure>
    <time_frame>six month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Hospitalization for worsening heart failure</measure>
    <time_frame>six month</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Heart Failure</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, urine.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The elegible individuals are patients of a tertiary cardiology hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 80 years old

          -  Heart failure diagnosis of different etiologies

          -  Left ventricular ejection fraction &lt; 50% in the past 2 years

        Exclusion Criteria:

          -  Patients with impaired cognition due to advanced dementia syndrome or severe
             psychiatric disorder

          -  Patients without telephone access

          -  Patients that refused to participate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre C Pereira, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Institute - Clinical Hospital  - University of São Paulo Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandre C Pereira, MD, PhD</last_name>
    <phone>55-11-2661-5543</phone>
    <email>alexandre.pereira@incor.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luciana Gioli-Pereira, MD, PhD</last_name>
    <phone>55-11-2661-5081</phone>
    <email>lu_gioli@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Institute - Clinical Hospital - University of São Paulo Medical School</name>
      <address>
        <city>Sao Paulo</city>
        <zip>050403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luciana Gioli-Pereira, MD, PhD</last_name>
      <phone>55-11-2661-5081</phone>
      <email>lu_gioli@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Luciana Gioli-Pereira, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 20, 2014</lastchanged_date>
  <firstreceived_date>January 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Electronic medical records</keyword>
  <keyword>Genomics</keyword>
  <keyword>Biobank</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
